Zulu
English French German Portuguese Spanish Russian Japanese Korean Arabic Irish Greek Turkish Italian Danish Romanian Indonesian Czech Afrikaans Swedish Polish Basque Catalan Esperanto Hindi Lao Albanian Amharic Armenian Azerbaijani Belarusian Bengali Bosnian Bulgarian Cebuano Chichewa Corsican Croatian Dutch Estonian Filipino Finnish Frisian Galician Georgian Gujarati Haitian Hausa Hawaiian Hebrew Hmong Hungarian Icelandic Igbo Javanese Kannada Kazakh Khmer Kurdish Kyrgyz Latin Latvian Lithuanian Luxembou.. Macedonian Malagasy Malay Malayalam Maltese Maori Marathi Mongolian Burmese Nepali Norwegian Pashto Persian Punjabi Serbian Sesotho Sinhala Slovak Slovenian Somali Samoan Scots Gaelic Shona Sindhi Sundanese Swahili Tajik Tamil Telugu Thai Ukrainian Urdu Uzbek Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Kinyarwanda Tatar Oriya Turkmen Uyghur
Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Feng Sizhou

Isikhungo Sokufakelwa Kwamaseli Esiqu
Isazi Esiyinhloko Sezokwelapha, Udokotela Oyinhloko, Umfundisi Wobudokotela

Udokotela Omkhulu Webanga Lesi-2, Umphathi Wezobudokotela (Owe-Postdoctoral), Uchwepheshe Oyinhloko Wokufakelwa Nokutheleleka Esibhedlela Se-Hematology Se-Chinese Academy of Medical Sciences. Uphinde abe yisekela likasihlalo weKomidi Elikhethekile Lezifo Ze-Pharmacogenetic le-Chinese Pharmacological Society, isekela likasihlalo weKomidi Elikhethekile Lokuxilongwa Nokwelashwa Kwezifo Ze-Hematological Le-Chinese Society of Research Hospitals, isekela likasihlalo weKomidi Elikhethekile Lokufakelwa Kwamaseli E-Hematopoietic Stem Cell le-China Primary Health Care Foundation, ilungu lekomidi le-Branch of Prevention and Control of Bacterial Infections and Drug Resistance of the Chinese Medical Association, isekela likamholi weqembu elilwa nokutheleleka le-Branch of Hematology ye-Chinese Medical Association, kanye neKomidi Elikhethekile Le-Geriatric Oncology ye-Tianjin Anti-Cancer Association. Umqondisi weKomidi Elikhethekile Le-Tianjin Anti-Cancer Association Geriatric Tumor. Ugxile ekuxilongweni nasekwelashweni kwezifo ezahlukahlukene ze-hematological, futhi unolwazi olukhethekile ekufakweni kwamaseli e-hematopoietic stem cell ezifweni ze-hematological kanye nokuxilonga nokwelashwa kwezifo ezigulini ze-hematological. Unekhono eliyingqayizivele kanye nezinga lokuthuthukisa uhlelo lokwelashwa kwangaphambi kokufakelwa kwamaseli e-hematopoietic stem, ukuxilongwa ngesikhathi kanye nokwelashwa kwezinkinga ezinkulu ezihlobene nokufakelwa kanye nokuvimbela ukubuyela emuva kokufakelwa, kanye nokuxilongwa nokwelashwa kokutheleleka okuhlangene ezigulini ezinezifo ze-hematological, futhi ubelokhu ehilelekile emsebenzini wezokwelapha nowokuqala wezifo ze-hematological iminyaka engama-36. Uthathe futhi wabamba iqhaza emisebenzini eminingi ye-National Natural Science Foundation of China, i-Key Discipline Construction Fund yoMnyango Wezempilo, amaphrojekthi ocwaningo lwesayensi ka-National 863 kanye namaphrojekthi angaphezu kwe-10 e-Tianjin Natural Science Foundation, njll. Ushicilele amaphepha angaphezu kwe-100 kuma-SCI kanye namajenali ayinhloko njengombhali wokuqala nombhali ohambisanayo, futhi unikezwe imiklomelo yentuthuko yesayensi nezobuchwepheshe yesifundazwe neyongqongqoshe, uDokotela wokuqala odumile waseTianjin, owathola i-Tianjin Meyi 1st Labor Medal, kanye "noDokotela Omuhle" owaneliswa ngabantu baseTianjin. "UDokotela Omuhle".

Feng Sizhou